Blake, H.
Carlisle, S.
Fothergill, L.
Hassard, J.
Favier, A.
Corner, J.
Ball, J. K.
Denning, C.
Article History
Received: 18 November 2021
Accepted: 10 June 2022
First Online: 2 August 2022
Declarations
:
: The study was carried out in accordance with the Helsinki Declaration. The process evaluation ran alongside an asymptomatic SARS-CoV-2 testing service (Service Registration: UKAS 307727–02-01). The process evaluation is registered on ExternalRef removed (Identifier: NCT05045989). Ethical approval was granted by University of Nottingham Faculty of Medicine & Health Sciences Research Ethics Committee (Ref: FMHS 96-0920 amendment no 6: 26.04.2021, approved on 4th May 2021, title: 'Extended longitudinal study of SARS Coronavirus type 2 infection in university staff and students through enhanced SARS2 coronavirus testing and follow-up') .There was a two-step approval process to take part in RB-TPP. First step was an online privacy notice, which contained consenting to have saliva samples tested for presence of SARS-CoV-2 RNA and, if positive, for follow-up analysis of that sample to include virus sequencing but excluding any human DNA sequence analysis. This also asked if participants would be willing to be approached for the purposes of research. Next, there was a separate online consent form for research participation. Participants in the process evaluation then provided additional written informed consent online prior to interview or focus groups. Participant interviews were transcribed and de-identified. All participants were assigned an identifier for anonymity and reporting purposes. All data were kept confidential.
: Not applicable.
: CD is Academic Lead and cofounder of the University of Nottingham Asymptomatic Testing Service (UoN ATS). AF and JKB are cofounders of UoN ATS. JC sits on the University of Nottingham Executive Board. None were involved in process evaluation data collection or analysis. HB is a behavioural advisor for the ATS; JKB is ATS virology advisor. Neither were involved in service delivery. SC, LF, JH reported no potential conflicts of interests.